Agent-based modelling to simulate cell- and multiscale problems in biology - Minisymposium at ECCOMAS 2024

Our Technical Coordinator, Vasileios Vavourakis, and our Spokesperson, Roman Bauer, together with Mariam-Eleni Oraiopoulou, Arnau Montagud, Marco Manca, and Alfonso Caiazzo, are the organizers of the minisymposium "agent-based modelling to simulate cell- and multiscale problems in biology", at ECCOMAS, 3rd-7th June 2024, in Lisbon (Portugal).


The purpose of this minisymposium is to act as a forum for investigators to present the state of the art in ABM in biology and life sciences, with a focus on pathophysiology of chronic (e.g., neuro-developmental and neurodegenerative disorders, cancer, diabetes, chronic inflammation) and communicable diseases (viral infections, parasitic disorders, etc.). Together, we aim to foster the exchange of knowledge and ideas across multiple disciplines: mathematics, physics, computer science, engineering, biology, medicine.

We welcome contributions addressing challenges related to mathematical and computational modelling using ABM with particular emphasis in:

• cross-scale (from organ to tissue, cell, protein and molecular level) ABM simulations;

• challenges in numerical techniques –including high-performance computing procedures– for single scale or/and multiscale agent-based models;

• benchmarking and calibration of ABM in problems related to systems biology;

• simulations that integrate in vitro and/or in vivo laboratory experiments for ABM initialization, parametrization and/or validation;

• prognostic ABM in drug delivery, nanomedicine, immunotherapy, and radiation treatment, with special focus on optimisation of trials and in vivo/ex vivo models substitution/complementarity.


Abstracts submission is now open!! 

Abstracts must be submitted electronically via the conference website. Below are a few important dates you might want to save on your calendar:

  • January 15, 2024: Deadline for presenting a one page abstract
  • March 18, 2024: Deadline for speaker registration
Please do not hesitate to get in touch with the ECCOMAS 2024 Secretariat for any question concerning submission.

Comments

Post a Comment

Popular posts from this blog

BioDynaMo @ Foresight Institute

Image
 Our spokesperson  Dr Bauer 's research focusses on the computational modelling and analysis of biological dynamics, in particular those of the brain. His highly interdisciplinary research involves modern computing approaches, biological expertise, innovative machine learning methods and IT- related collaboration, as we know. As you probably remember, Dr Bauer has been a 2024 Fellow of the Foresight Institute  and thus, he has had the opportunity to share his reflections about computational biology with a wider audience of brilliant people. Here we share two of his recent interviews/lectures, of course on topics we hold very dear. 1) Computational Modeling in Biomedicine: With the Eggs in Multiple Baskets Abstract :  Computational modeling is one of the pillars of the scientific method. Unsurprisingly, it has also become paramount for biomedical research when it entails various data modalities and numerous biological, physical and chemical processes. Moreover, t...
Read more

Mechanistic model of radiotherapy-induced lung fibrosis using coupled BioDynaMo and Monte Carlo simulations

Image
 We are proud to announce the newly published manuscript " Mechanistic model of radiotherapy-induced lung fibrosis using coupled 3D agent-based and Monte Carlo simulations " by Nicolò Cogno , Roman Bauer , and Marco Durante , appearing on  Communications Medicine volume 4, Article number: 16 (2024). Fig. 1: Alveolar segment model in TOPAS-nBio . In this work, the authors develop and characterize a coupled 3D agent-based – Monte Carlo model that mechanistically simulates the onset of the radiation-induced lung fibrosis in an alveolar segment, laying thus the groundwork for further investigating the effects of different radiotherapeutic treatments on the onset of radiation-induced lung fibrosis via mechanistic modelling. The featured 3D agent based models are (of course) developed using the open-source platform BioDynaMo , and the implementation details have been shared in previous work by the same trio  here , and here . Without further ado, if you are interested in ...
Read more

BioDynaMo in 2024 - End of the year remarks, and Holidays greetings

Image
Dear all,  as we are approaching the end of 2024, we would like to take a moment to reflect on our collaborative achievements within the BioDynaMo community. It has been a year marked by innovation, resilience, and shared commitment to advancing our understanding of various biological systems through innovative computational modelling. This year, the consortium had several important successes. We would like to specifically mention/highlight: The paper presenting BioDynaMo’s application to cancer treatment. Radiation-induced fibrosis is a major risk factor in radiotherapy for lung cancer patients. BioDynaMo members including our Nicolo as first author published in the very prestigious Nature Communications Medicine journal, showing how BioDynaMo can be used to simulate the impact of radiation on the lung on a single cell level. Such modelling can be used to improve radiotherapy: https://www.nature.com/articles/s43856-024-00442-w Also in the domain of oncology, a study leve...
Read more